Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BUSSEL, James B")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 76

  • Page / 4
Export

Selection :

  • and

Therapeutic Approaches to Secondary Immune Thrombocytopenic PurpuraBUSSEL, James B.Seminars in hematology. 2009, Vol 46, Num 1, issn 0037-1963, S44-S58, SUP2Article

The Changing Landscape of Secondary ITPBUSSEL, James B.Seminars in hematology. 2009, Vol 46, Num 1, issn 0037-1963, 63 p., SUP2Serial Issue

Recent advances in the treatment of idiopathic thrombocytopenic purpuraBUSSEL, James B.Seminars in hematology. 1998, Vol 35, Num 1, issn 0037-1963, 65 p., SUP1Serial Issue

Fetal and neonatal alloimmune thrombocytopenia : progress and ongoing debatesBUSSEL, James B; PRIMIANI, Andrea.Blood reviews. 2008, Vol 22, Num 1, pp 33-52, issn 0268-960X, 20 p.Article

Thrombopoietic Agents in Immune ThrombocytopeniaGHANIMA, Walled; BUSSEL, James B.Seminars in hematology. 2010, Vol 47, Num 3, pp 258-265, issn 0037-1963, 8 p.Article

Toxicities of the Thrombopoietic Growth FactorsCUKER, Adam.Seminars in hematology. 2010, Vol 47, Num 3, pp 289-298, issn 0037-1963, 10 p.Article

Management of Chemotherapy-Induced Thrombocytopenia : Current Status of Thrombopoietic AgentsVADHAN-RAJ, Saroj.Seminars in hematology. 2009, Vol 46, Num 1, issn 0037-1963, S26-S32, SUP2Article

Thrombocytopenia in Myelodysplastic Syndromes and MyelofibrosisBORUCHOV, Adam M.Seminars in hematology. 2009, Vol 46, Num 1, issn 0037-1963, S37-S43, SUP2Article

Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpuraBUSSEL, J. B.Seminars in hematology. 2000, Vol 37, Num 1, pp 1-4, issn 0037-1963, SUP1Article

Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpuraSCARADAVOU, A; BUSSEL, J. B.Seminars in hematology. 1998, Vol 35, Num 1, pp 52-57, issn 0037-1963, SUP1Article

New Thrombopoietic AgentsBUSSEL, James B; KUTER, David J.Seminars in hematology. 2010, Vol 47, Num 3, issn 0037-1963, 90 p.Serial Issue

The effect of anti-CD40 ligand in immune thrombocytopenic purpuraPATEL, Vivek L; SCHWARTZ, Joseph; BUSSEL, James B et al.British journal of haematology. 2008, Vol 141, Num 4, pp 545-548, issn 0007-1048, 4 p.Article

How I treat idiopathic thrombocytopenic purpura (ITP)CINES, Douglas B; BUSSEL, James B.Blood. 2005, Vol 106, Num 7, pp 2244-2251, issn 0006-4971, 8 p.Article

Intracranial hemorrhage in immune thrombocytopenic purpura: A retrospective analysisBUTROS, Linda J; BUSSEL, James B.Journal of pediatric hematology/oncology. 2003, Vol 25, Num 8, pp 660-664, issn 1077-4114, 5 p.Article

Overview of idiopathic thrombocytopenic purpura : New approach to refractory patientsBUSSEL, James B.Seminars in oncology. 2000, Vol 27, Num 6, pp 91-98, issn 0093-7754, SUP12Conference Paper

Overview of Platelet TransfusionMCCULLOUGH, Jeffrey.Seminars in hematology. 2010, Vol 47, Num 3, pp 235-242, issn 0037-1963, 8 p.Article

Traditional and New Approaches to the Management of Immune Thrombocytopenia: Issues of When and Who to TreatBUSSEL, James B.Hematology/oncology clinics of North America. 2009, Vol 23, Num 6, issn 0889-8588, 1329-1341, viii [14 p.]Article

Advances in the management of alloimmune thrombocytopeniaMURPHY, Michael F; BUSSEL, James B.British journal of haematology. 2007, Vol 136, Num 3, pp 366-378, issn 0007-1048, 13 p.Article

Immune thrombocytopenic purpuraPSAILA, Bethan; BUSSEL, James B.Hematology/oncology clinics of North America. 2007, Vol 21, Num 4, issn 0889-8588, vii, 743-759 [18 p.]Article

Autoantibodies and autoantigens in chronic immune thrombocytopenic purpuraMCMILLAN, R.Seminars in hematology. 2000, Vol 37, Num 3, pp 239-248, issn 0037-1963Article

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpuraBUSSEL, James B; HANNA, Kim.American journal of hematology. 2007, Vol 82, Num 3, pp 192-198, issn 0361-8609, 7 p.Article

Alloimmune thrombocytopenia in the fetus and newbornBUSSEL, James B.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 3, pp 245-252, issn 0094-6176Article

Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in childrenTARANTINO, M. D.Seminars in hematology. 2000, Vol 37, Num 1, pp 35-41, issn 0037-1963, SUP1Article

Long-term outcome of splenectomy for idiopathic thrombocytopenic purpuraBELL, W. R.Seminars in hematology. 2000, Vol 37, Num 1, pp 22-25, issn 0037-1963, SUP1Article

Treatment of acute immune thrombocytopenic purpuraTARANTINO, M. D; GOLDSMITH, G.Seminars in hematology. 1998, Vol 35, Num 1, pp 28-35, issn 0037-1963, SUP1Article

  • Page / 4